Facebook
Twitter
LinkedIn
ForwardTurnover Talk: Allied Health Clinical Procedures
Discussion of considerations, technique and common office procedures in gynecologic oncology.
Turnover Talk: Allied Health Lynch Syndrome
Discussion regarding diagnosis and management of LYNCH syndrome.
Turnover Talk: Allied Health PARPs
Discussion of current trials and indications for PARPs in Ovarian cancer.
Turnover Talk: Allied Health Sexual Health
Discussion of sexual health issues among gynecologic oncology patients.
Turnover Talk: Allied Health Wound Care
Discussion of issues related to delayed wound healing, wound care techniques, and the role of wound care specialists.
Turnover Talk: Current Treatment Decisions for Front Line Ovarian Cancer
Discussion of maintenance therapy with PARPi, or bevacizumab, and improvement in progression free survival after front line treatment for advanced high grade epithelial ovarian cancer
Turnover Talk: Evaluation and Management Coding for 2021
Discussion of 2021 changes to E&M coding for outpatient visits for billing by time and medical complexity.
Turnover Talk: Immunotherapy Toxicity
Review of immunotherapy toxicity including timeline and symptoms of endocrinopathies, nephritis, hepatitis, colitis, pneumonitis; treatment for IRAEs; rechallenging patients after resolution of IRAEs.
Turnover Talk: Molecular Testing and Patient Selection in Ovarian Cancer
A brief discussion of homologous recombination deficiency, loss of heterozygosity, and molecular markers in ovarian cancer, and how this can guide therapy.
Turnover Talk: Novel Discoveries in Endometrial Cancer: Are we finally making progress?
Novel treatments in advanced or recurrent endometrial cancer including targeted therapies and immunotherapies.